The majority of technology vendors––75 percent––believe advanced analytics and AI will be among the top areas of focus for healthcare companies in 2019, according to a survey by Damo Consulting.

Previously established frameworks for creating breast cancer screening bundled payment models are achievable, according to a new study published in the Journal of the American College of Radiology. The approaches could also incorporate the rise of digital breast tomosynthesis (DBT).

The FDA published its final guidance Jan. 22 for ensuring medical devices meet “more modern safety and performance criteria” before being cleared through the agency’s 510(k) review process.

Employees from St. Joseph Hospital in Eureka, California, have planned a rally for Jan. 24 to protest the hospital’s decision to lay off two radiology technologist assistants.

The Alliance for Artificial Intelligence in Healthcare (AAIH) has officially launched after the board of directors held the organization’s inaugural meeting Jan. 9 in San Francisco.

A report from Persistence Marketing Research predicts the demand for neurovascular thrombectomy devices (NTDs), particularly stent retrievers, will surge in the near future alongside a growing prevalence of cerebral infarction and ischemic stroke.

The new evidence-based clinical recommendations seek to help labs better use quantitative image analysis (QIA) in HER2 testing for breast cancer.

Following a series of valsartan recalls over carcinogenic impurities, at least three sellers of the popular blood-pressure medication hiked their prices, the Wall Street Journal reported.